Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Celling Biosciences logo — Market leader focused on the science, R&D, & education of au...

Celling Biosciences

Market leader focused on the science, R&D, & education of autologous cellular therapy and its synergies.

Founded 2006 United States Austin, United States 47 employees Biotechnology

General Information

Company Name Celling Biosciences
Founded Year 2006
Location United States Austin, United States +1
Employees 47
Industries Biotechnology
Social

Get notified when Celling Biosciences moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Celling Biosciences

Celling Biosciences is a market leader in the biotechnology industry, focusing on the science, R&D, and education of autologous cellular therapy and its synergies. Founded in 2006 and headquartered in the United States, the company is dedicated to advancing the future of medicine through the innovation of point-of-care, autologous regenerative cell therapies. The company's slogan succinctly captures its core focus on advancing the science and research of autologous cellular therapy. Celling Biosciences' commitment to innovation is evident in its description, highlighting their team's dedication to developing point-of-care systems, innovative surgical techniques, and technology platforms to create the optimal environment for regenerative cell therapies. With a mission to promote healing and the regeneration of tissue, Celling Biosciences stands at the forefront of developing cutting-edge solutions in the biotechnology space. As of now, the last investment and its associated details are not available, but the company's pioneering work in the field signals a promising trajectory.

Taxonomy: regenerative medicine, cell therapy, R&D, point-of-care systems, surgical techniques, technology platforms, autologous therapy, regenerative cell therapies, tissue regeneration, scientific innovation, biomedical engineering

No funding data available for Celling Biosciences yet.

Get notified when Celling Biosciences raises funding

Celling Biosciences Alternatives & Competitors

Celling Biosciences vs
InGeneron
InGeneron United States

Unlocking Regenerative Cell Therapy

Series Unknown
18 employees
Biotechnology, Health Care
Celling Biosciences vs
StemSight - Vision Unlimited
StemSight - Vision Unlimited Finland

Curing blindness with regenerative cell therapies.

Seed
16 employees
Biotechnology, Health Care
Celling Biosciences vs
Aglaris Ltd Group
Aglaris Ltd Group United Kingdom

Aglaris Ltd. together with Aglaris Cell, Changing Cellular Manufacturing: More productive, more reli...

Grant
11 employees
Biotechnology, Health Care

FAQ About Celling Biosciences

Market leader focused on the science, R&D, & education of autologous cellular therapy and its synergies.
Celling Biosciences was founded in 2006.
Celling Biosciences is headquartered in Austin, United States.
Celling Biosciences operates in the following industries: Biotechnology.
Celling Biosciences has approximately 47 employees.
Top alternatives and competitors to Celling Biosciences include InGeneron, StemSight - Vision Unlimited, Aglaris Ltd Group, The International Stem Cell Institute, Vestem. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Celling Biosciences and InGeneron are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Celling Biosciences and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy